a 802715 has been researched along with lisofylline in 2 studies
| Studies (a 802715) | Trials (a 802715) | Recent Studies (post-2010) (a 802715) | Studies (lisofylline) | Trials (lisofylline) | Recent Studies (post-2010) (lisofylline) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 105 | 6 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
| Binder, A; Bohm, L; Theron, T | 1 |
2 other study(ies) available for a 802715 and lisofylline
| Article | Year |
|---|---|
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |
Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Topics: Caffeine; Cell Cycle; Dose-Response Relationship, Drug; Enzyme Inhibitors; G2 Phase; Gentian Violet; Growth Inhibitors; Humans; Indicators and Reagents; Mitosis; Molecular Structure; Nocodazole; Pentoxifylline; Radiation-Sensitizing Agents; S Phase; Time Factors; Tumor Cells, Cultured; Xanthines | 2000 |